1. Home
  2. |Insights
  3. |ACI 3rd Annual Paragraph IV Disputes Conference

ACI 3rd Annual Paragraph IV Disputes Conference

Event | 04.27.09 - 04.28.09, 12:00 AM UTC - 12:00 AM UTC

In its third year, ACI's conference on Paragraph IV Disputes is the ONLY event where both brand name and generic companies can come to hear insights from a top-notch faculty on every facet of Paragraph IV litigation, from pre-litigation concerns to the commencement of the suit to final adjudication – and every step in between.

With hundreds of billions of dollars in product sales currently subjected to Paragraph IV litigation, it is imperative that both brand and generic companies, and their counsel, have the offensive moves and defensive plays they respectively need in this high stakes arena of pharmaceutical patent endgame litigation.

In this high stakes and ruthless endgame, not a moment can be lost. Featuring preeminent patent litigators and in-house industry experts from both branded and generic companies, along with representatives from the FTC and preeminent judges, you cannot afford to miss this event.

Teresa Rea is the moderator on the session entitled "Positioning Your Patent/Product for Success at Trial: Crafting the Initial Pleadings, Seeking Declaratory Judgment and Managing the Markman Hearing.

For more information, please visit these areas: Intellectual Property, Intellectual Property Litigation

Insights

Event | 02.20.25

Has the Buss Stopped? Recoupment Today

Has the Buss Stopped? Recoupment Today: In 1997, the California Supreme Court decided Buss v. Superior Court. In Buss, the court concluded that a liability insurer that defended a mixed action could seek reimbursement from the insured for the defense costs associated with the claims that were not even potentially covered. Since then, numerous courts have held that insurers are entitled to recoup their defense costs associated with uncovered claims or causes of action. On the other hand, a significant number of courts have rejected insurers’ right to recoupment, at least in the absence of a policy provision granting the insurer that right. Some commentators have even suggested that the current judicial trend might be away from permitting insurers to recoup their defense costs. Is that correct? Has the Buss stopped? This panel of coverage experts will analyze insurers’ claimed right to recoupment today, and offer their perspectives on what the law on recoupment should perhaps be and might be in the future.

View All Insights